  Inflammation of brain tissue is a complex response of the immune system to
the presence of toxic compounds or to cell injury, leading to a cascade of
pathological processes that include glial cell activation. Noninvasive magnetic
resonance imaging markers of glial reactivity would be very useful for in vivo
detection and monitoring of inflammation processes in the brain, as well as for
evaluating the efficacy of personalized treatments. Due to their specific
location in glial cells, myo-inositol (mIns) and choline compounds (tCho) seem
the best candidates for probing glial-specific intra-cellular compartments.
However, their concentrations quantified using conventional proton magnetic
resonance spectroscopy (MRS) are not specific for inflammation. In contrast, it
has been recently suggested that mIns intra-cellular diffusion, measured using
diffusion-weighted MRS (DW-MRS) in a mouse model of reactive astrocytes, could
be a specific marker of astrocytic hypertrophy. In order to evaluate the
specificity of both mIns and tCho diffusion to inflammation-driven glial
alterations, we performed DW-MRS in the corpus callosum of cuprizone-fed mice
after 6 weeks of intoxication and evaluated the extent of astrocytic and
microglial alterations using immunohistochemistry. Both mIns and tCho apparent
diffusion coefficients were significantly elevated in cuprizone-fed mice
compared to control mice, while histologic evaluation confirmed the presence of
severe inflammation. Additionally, mIns and tCho diffusion showed,
respectively, strong and moderate correlations with histological measures of
astrocytic and microglial area fractions, confirming DW-MRS as a promising tool
for specific detection of glial changes under pathological conditions.
